Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer

(2021) Wei-Xiong Xia et al.   CLINICAL CANCER RESEARCH

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

(2019) Seth Helfenstein et al.   Radiation Oncology

Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma

(2019) Ryan T. Morse et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

(2018) Vanita Noronha et al.   JOURNAL OF CLINICAL ONCOLOGY

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer

(2018) So Yeon Lee et al.   MEDICINE

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

(2017) Petr Szturz et al.   ONCOLOGIST

A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer

(2016) Sjoukje F. Oosting et al.   ORAL ONCOLOGY

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review

(2015) Primož Strojan et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

(2012) Jay S. Cooper et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase II Feasibility Trial of Adjuvant Chemoradiotherapy with 3-weekly Cisplatin for Japanese Patients with Post-operative High-risk Squamous Cell Carcinoma of the Head and Neck

(2012) N. Kiyota et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

(2012) Din-Li Tsan et al.   Radiation Oncology

Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients

(2011) Zulfiquer OTTY et al.   Asia-Pacific Journal of Clinical Oncology

Concomitant Weekly Cisplatin and Radiotherapy for Head and Neck Cancer

(2011) A. Homma et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial

(2010) A. Sharma et al.   ANNALS OF ONCOLOGY

Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial

(2010) M. Rampino et al.   CLINICAL ONCOLOGY

Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: A retrospective comparison from New Cross Hospital, Wolverhampton, UK

(2008) Kean F. Ho et al.   ACTA ONCOLOGICA